NasdaqGS - Nasdaq Real Time Price USD

Progyny, Inc. (PGNY)

20.52
-0.37
(-1.77%)
At close: May 23 at 4:00:01 PM EDT
20.45
-0.07
(-0.34%)
After hours: May 23 at 4:10:12 PM EDT
Loading Chart for PGNY
  • Previous Close 20.89
  • Open 20.74
  • Bid 14.80 x 200
  • Ask 26.39 x 200
  • Day's Range 20.49 - 20.81
  • 52 Week Range 13.39 - 30.42
  • Volume 786,006
  • Avg. Volume 1,521,895
  • Market Cap (intraday) 1.759B
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) 36.00
  • EPS (TTM) 0.57
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 26.25

Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. The company offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. It also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services. In addition, the company offers assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

www.progyny.com

675

Full Time Employees

December 31

Fiscal Year Ends

Recent News: PGNY

View More

Performance Overview: PGNY

Trailing total returns as of 5/23/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

PGNY
18.96%
S&P 500 (^GSPC)
1.34%

1-Year Return

PGNY
24.42%
S&P 500 (^GSPC)
10.16%

3-Year Return

PGNY
40.83%
S&P 500 (^GSPC)
46.03%

5-Year Return

PGNY
18.25%
S&P 500 (^GSPC)
96.34%

Compare To: PGNY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: PGNY

View More

Valuation Measures

Annual
As of 5/23/2025
  • Market Cap

    1.76B

  • Enterprise Value

    1.53B

  • Trailing P/E

    36.00

  • Forward P/E

    13.16

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.56

  • Price/Book (mrq)

    3.77

  • Enterprise Value/Revenue

    1.26

  • Enterprise Value/EBITDA

    19.94

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.33%

  • Return on Assets (ttm)

    5.99%

  • Return on Equity (ttm)

    10.11%

  • Revenue (ttm)

    1.21B

  • Net Income Avi to Common (ttm)

    52.5M

  • Diluted EPS (ttm)

    0.57

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    256.12M

  • Total Debt/Equity (mrq)

    6.19%

  • Levered Free Cash Flow (ttm)

    200.38M

Research Analysis: PGNY

View More

Company Insights: PGNY

Research Reports: PGNY

View More

People Also Watch